AbbVie back on track at PBAC

By Megan Brodie 3 weeks ago | In Industry
  • 3 weeks ago
PBAC Chair Professor Robyn Ward

6 May 2024 AbbVie’s combination therapy for advanced Parkinson’s Disease, VYALEV (foslevodopa + foscarbidopa), will…

This is subscriber-only content. Please login to continue reading.